These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 7887358

  • 1. Screening for Chlamydia trachomatis infection.
    Skolnik NS.
    Am Fam Physician; 1995 Mar; 51(4):821-6. PubMed ID: 7887358
    [Abstract] [Full Text] [Related]

  • 2. Periodic health examination, 1996 update: 2. Screening for chlamydial infections. Canadian Task Force on the Periodic Health Examination.
    Davies HD, Wang EE.
    CMAJ; 1996 Jun 01; 154(11):1631-44. PubMed ID: 8646651
    [Abstract] [Full Text] [Related]

  • 3. TestPack Chlamydia for chlamydial detection in physicians' offices.
    Mercer L, Marchiewicz B, Coleman P, Staruck C, Hajj S.
    J Reprod Med; 1990 Dec 01; 35(12):1141-4. PubMed ID: 2283632
    [Abstract] [Full Text] [Related]

  • 4. Chlamydia trachomatis genital infections--United States, 1995.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 1997 Mar 07; 46(9):193-8. PubMed ID: 9072679
    [Abstract] [Full Text] [Related]

  • 5. Rates of Chlamydia trachomatis testing and chlamydial infection in pregnant women.
    Lawton B, Rose S, Bromhead C, Brown S, MacDonald J, Shepherd J.
    N Z Med J; 2004 May 21; 117(1194):U889. PubMed ID: 15156207
    [Abstract] [Full Text] [Related]

  • 6. Female genital Chlamydia trachomatis infection: where are we heading?
    Mylonas I.
    Arch Gynecol Obstet; 2012 May 21; 285(5):1271-85. PubMed ID: 22350326
    [Abstract] [Full Text] [Related]

  • 7. Overestimation of complication rates in evaluations of Chlamydia trachomatis screening programmes--implications for cost-effectiveness analyses.
    van Valkengoed IG, Morré SA, van den Brule AJ, Meijer CJ, Bouter LM, Boeke AJ.
    Int J Epidemiol; 2004 Apr 21; 33(2):416-25. PubMed ID: 15082651
    [Abstract] [Full Text] [Related]

  • 8. [Chlamydia trachomatis urogenital infections in women. Best diagnostic approaches].
    Hamdad F, Orfila J, Boulanger JC, Eb F.
    Gynecol Obstet Fertil; 2004 Dec 21; 32(12):1064-74. PubMed ID: 15589784
    [Abstract] [Full Text] [Related]

  • 9. Risk assessment and other screening options for gonorrhoea and chlamydial infections in women attending rural Tanzanian antenatal clinics.
    Mayaud P, Grosskurth H, Changalucha J, Todd J, West B, Gabone R, Senkoro K, Rusizoka M, Laga M, Hayes R.
    Bull World Health Organ; 1995 Dec 21; 73(5):621-30. PubMed ID: 8846488
    [Abstract] [Full Text] [Related]

  • 10. [Opportunistic screening for genital infections with Chlamydia trachomatis in sexually active population of Amsterdam. II. Cost-effectiveness analysis of screening women].
    Postma MJ, Welte R, van den Hoek JA, van Doornum GJ, Coutinho RA, Jager JC.
    Ned Tijdschr Geneeskd; 1999 Mar 27; 143(13):677-81. PubMed ID: 10321301
    [Abstract] [Full Text] [Related]

  • 11. Reporting of chlamydial infection--Massachusetts, January-June 2003.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2005 Jun 10; 54(22):558-60. PubMed ID: 15944526
    [Abstract] [Full Text] [Related]

  • 12. Chlamydia trachomatis genital infections.
    Fisher MA.
    W V Med J; 1993 Aug 10; 89(8):331-4. PubMed ID: 8372472
    [Abstract] [Full Text] [Related]

  • 13. Is it justifiable to perform screening tests for Chlamydia trachomatis in pregnant women?
    Perlik M, Drews K, Pieńskowski W.
    Med Wieku Rozwoj; 2005 Aug 10; 9(1):117-25. PubMed ID: 16082073
    [Abstract] [Full Text] [Related]

  • 14. [Screening for asymptomatic Chlamydia trachomatis infection in pregnancy; cost-effectiveness favorable at a minimum prevalence rate of 3% or more].
    Postma MJ, Bakker A, Welte R, van Bergen JE, van den Hoek JA, de Jong-van den Berg LT, Jager JC.
    Ned Tijdschr Geneeskd; 2000 Dec 02; 144(49):2350-4. PubMed ID: 11129971
    [Abstract] [Full Text] [Related]

  • 15. [Chlamydia trachomatis as an etiological factor of marital infertility--is a routine diagnostics worth to perform?].
    Murawski M, Matusiak M, Gryboś M.
    Wiad Lek; 2007 Dec 02; 60(9-10):445-8. PubMed ID: 18350719
    [Abstract] [Full Text] [Related]

  • 16. Chlamydia trachomatis during pregnancy. To screen or not to screen?
    Carroll JC.
    Can Fam Physician; 1993 Jan 02; 39():97-102. PubMed ID: 8435566
    [Abstract] [Full Text] [Related]

  • 17. Chlamydia trachomatis infections: screening, diagnosis, and management.
    Mishori R, McClaskey EL, WinklerPrins VJ.
    Am Fam Physician; 2012 Dec 15; 86(12):1127-32. PubMed ID: 23316985
    [Abstract] [Full Text] [Related]

  • 18. Chlamydia trachomatis: time for screening?
    Spiliopoulou A, Lakiotis V, Vittoraki A, Zavou D, Mauri D.
    Clin Microbiol Infect; 2005 Sep 15; 11(9):687-9. PubMed ID: 16104982
    [Abstract] [Full Text] [Related]

  • 19. Screening and treatment to prevent sequelae in women with Chlamydia trachomatis genital infection: how much do we know?
    Gottlieb SL, Berman SM, Low N.
    J Infect Dis; 2010 Jun 15; 201 Suppl 2():S156-67. PubMed ID: 20470051
    [Abstract] [Full Text] [Related]

  • 20. Incidence of genital Chlamydia trachomatis infection in the male partners attending an infertility clinic.
    Arya R, Mannion PT, Woodcock K, Haddad NG.
    J Obstet Gynaecol; 2005 May 15; 25(4):364-7. PubMed ID: 16091321
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.